LXN

LXN

Target · Carboxypeptidase inhibitor

LXN Latexin

LXN (latexin) is a cytoplasmic protein and the only known protein inhibitor of zinc-dependent metallocarboxypeptidases. It belongs to the protease inhibitor I47 family and has been linked to haematopoietic stem cell regulation and inflammation. Browse Assay Genie's current range of LXN research reagents below, or read on for the biology behind the target.

Cytoplasmic proteinCarboxypeptidase inhibitorSilenced by hypermethylation
222 aa
Protein length
~26 kDa
Molecular weight
3q25.32
Gene locus
Protease inhibitor
Protein family
Target information

What is LXN (latexin)?

LXN encodes latexin, a protein inhibitor of carboxypeptidases. According to UniProt, it is a potent, non-competitive and hardly reversible inhibitor of CPA1, CPA2 and CPA4. NCBI Gene describes it as the only known protein inhibitor of zinc-dependent metallocarboxypeptidases, which makes it a distinctive tool for studying this group of proteases. UniProt also notes that latexin may play a role in inflammation.

Latexin is assigned to the protease inhibitor I47 (latexin) family and is found in the cytoplasm. The human LXN gene is located on chromosome 3, and mouse and rat each carry an ortholog named Lxn. Researchers working on this protein may look for an LXN antibody, an LXN ELISA kit or recombinant LXN protein to follow its levels in experimental systems.

Beyond protease inhibition, the NCBI Gene summary reports that latexin downregulates the population size of haematopoietic stem cells. This links the protein to the control of stem cell numbers. The same summary notes that LXN is downregulated in cancer cells because of promoter hypermethylation, so the LXN gene is also of interest in studies of epigenetic silencing in tumours.

Haematopoietic stem cell biology

Latexin downregulates haematopoietic stem cell population size, making LXN relevant to studies of stem cell number control.

Cancer epigenetics

LXN is downregulated in cancer cells through promoter hypermethylation, so it is studied as a target of epigenetic silencing.

Carboxypeptidase regulation

Latexin is a potent inhibitor of CPA1, CPA2 and CPA4, and the only known protein inhibitor of metallocarboxypeptidases.

Inflammation research

UniProt notes that latexin may play a role in inflammation, supporting investigation of LXN in inflammatory settings.

Background

LXN frequently asked questions

What does LXN do?

LXN encodes latexin, which inhibits the zinc-dependent metallocarboxypeptidases CPA1, CPA2 and CPA4 in a potent, non-competitive and hardly reversible manner. It may also play a role in inflammation, and it downregulates haematopoietic stem cell population size, according to UniProt and NCBI Gene.

Does LXN have other names or family members?

No aliases or previous symbols are listed for LXN. The protein is called latexin and belongs to the protease inhibitor I47 (latexin) family. NCBI Gene describes it as the only known protein inhibitor of zinc-dependent metallocarboxypeptidases.

Is LXN linked to cancer and conserved in other species?

NCBI Gene reports that LXN is downregulated in cancer cells because of promoter hypermethylation. Mouse and rat both have an ortholog called Lxn. For reactivity with a given species, check the datasheet of any product for its validated reactivity.

Explore

Related targets

Carboxypeptidases inhibited by latexin, which may be useful alongside LXN in protease regulation studies.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BS40; product specifications from Assay Genie datasheets.

LXN Product listing